Accelerating Access to Latin America Innovative...

By HEOR Staff Writer

November 25, 2025

Accelerating Access to Latin America Innovative Therapies In this update we outline a strategic vision for transforming Latin America's healthcare systems through innovation,...
Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023
Addressing AI Polyp Detection Gaps: A Roadmap for Evidence Generation and NHS...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset
Interchangeable Biosimilar Approval: FDA Greenlights Poherdy as First to Perjeta
Weight Loss: Advances in Hormone-Based Obesity Treatments
CTX310 Lipid Disorder: Phase 1 Trial Shows Promising LDL and Triglyceride Red...
Koselugo EU Approval: A Milestone in Treating Plexiform Neurofibromas for Adu...
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
NICE Endorses Darolutamide Prostate Cancer Treatment for Improved Patient Access
Fabhalta Kidney Treatment Shows Promise in Slowing Disease Progression for Ig...
Tukysa Breast Cancer Therapy Boosts Progression-Free Survival in Advanced Cases
Lurbinectedin SCLC Therapy: FDA Approval and Its Economic Implications